BREAST-TUMOR AND POLYMYOSITIS FOLLOWING CIMETIDINE THERAPY - A POSSIBLE ASSOCIATION

[1] ARELLA J, 1978, LANCET, V1, P624

[2] BATESON MC, 1977, LANCET, V2, P247

[3] BLACK MM, 1972, CANCER, V29, P338, DOI 10.1002/1097-0142(197202)29:2&lt

[4] 338::AID-CNCR2820290212&gt

[5] 3.0.CO

[6] 2-U

[7] CIMETIDINE, AN H2-ANTIHISTAMINE, STIMULATES PROLACTIN SECRETION IN MAN [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (02) : 367 - 370

[8] CREAN GP, 1981, NEW ENGL J MED, V304, P672

[9] CREAN GP, 1979, LANCET, V2, P797

[10] CELL-MEDIATED CYTOTOXICITY TO MUSCLE IN POLYMYOSITIS - EFFECT OF IMMUNOSUPPRESSION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (09) : 434 - 438

[1] ARELLA J, 1978, LANCET, V1, P624

[2] BATESON MC, 1977, LANCET, V2, P247

[3] BLACK MM, 1972, CANCER, V29, P338, DOI 10.1002/1097-0142(197202)29:2&lt

[4] 338::AID-CNCR2820290212&gt

[5] 3.0.CO

[6] 2-U

[7] CIMETIDINE, AN H2-ANTIHISTAMINE, STIMULATES PROLACTIN SECRETION IN MAN [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (02) : 367 - 370

[8] CREAN GP, 1981, NEW ENGL J MED, V304, P672

[9] CREAN GP, 1979, LANCET, V2, P797

[10] CELL-MEDIATED CYTOTOXICITY TO MUSCLE IN POLYMYOSITIS - EFFECT OF IMMUNOSUPPRESSION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (09) : 434 - 438